antiprimod has been researched along with Metastase in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dheer, S; Jacob, GS; Kaur, G; Picker, D; Sausville, EA; Shailubhai, K | 1 |
1 other study(ies) available for antiprimod and Metastase
Article | Year |
---|---|
Atiprimod is an inhibitor of cancer cell proliferation and angiogenesis.
Topics: Angiogenesis Inhibitors; Apoptosis; Caspase 3; Caspase 9; Caspases; Cations; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cells, Cultured; Collagen; Cytokines; DNA-Binding Proteins; Dose-Response Relationship, Drug; Down-Regulation; Drug Combinations; Endothelium, Vascular; Enzyme Activation; Fibroblast Growth Factor 2; Humans; Inhibitory Concentration 50; Laminin; Models, Chemical; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Proteoglycans; Spiro Compounds; STAT3 Transcription Factor; Trans-Activators; Vascular Endothelial Growth Factor A | 2004 |